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t
he nicotinic acetylcholine receptor (nAchr) is a li-
gand-gated ion channel which is incorporated into 
the postsynaptic membrane of neurons [1]. nAchr is 
composed of five homologous subunits, whose  transmem-
brane domains form an ion pore and the n-terminal do-
mains contain the binding sites for the ligand (Fig.1). One 
of the most common subtypes of nAchr receptor in mam-
malian nervous systems is a homopentameric, α7 nAchr 
(α7nAchr), and several neurodegenerative disorders 
are associated with its dysfunction [2].  An effective sys-
tem for the production of the individual subunits and oth-
er domains of nAchr is a prerequisite for studies focused 
on the receptor itself, and for the design of biomedical 
drugs to be used in the treatment of the disease. the ten-
dency of these proteins to form insoluble aggregates in so-
l u t i o n   m a k e s   t h e   d e v e l o p m e n t   o f   s u c h   s y s t e m s   d i f f i c u l t   [ 3 ] .                                                                                                                                    
recently, a research group from the uSA published the x-
ray structure of acetylcholine binding protein (AchBP) from 
Lymnaea stagnalis [4]. AchBP is a water-soluble protein com-
posed of five identical subunits. this protein shares 25% se-
quence homology with the extracellular domain of α7nAchrr 
(α7eD), and it is capable of interacting with some of the 
nAchr ligands (for example, acetylcholine, α-conotixins, and 
α-neurotoxins) [4]. It has been shown that replacing the frag-
ment of α7eD which is located between cys128 and cys142 
(the so-called cys-loop) with a homologous loop from AchBP 
increases the solubility of the domain [5].
During the past 10 years, cell-free systems, especially 
continuous-z exchange cell-free systems, have been success-
fully used in the production of recombinant proteins [7, 8]. 
these systems have some advantages over host-based gene 
expression systems: (i) the direct addition of special agents 
or co-factors into the reaction mixture can prevent the ag-
gregation of the target protein, and (ii) the method permits 
the synthesis of selectively labeled proteins which can then 
be used in structural studies. 
the main objective of the present study was the develop-
ment of an effective cell-free system for the production of reSeArcH ArtIcLeS
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human α7eD.  For this purpose, from a full-length gene of 
α7nAchr (a generous gift from Prof. J. Lindstrom) two mu-
tant α7eD genes were constructed, with substitutions that 
were intended to increase solubility. the first gene (α7ED/
C116S/Cys-loop) coded for α7eD with two substitutions: (i) 
unpaired cys116 was replaced by Ser [3], and (ii) cys-loop 
of α7eD (cys128-cys142) was replaced by cys-loop from 
AchBP [5].  An analysis of the model of α7eD [6] revealed 
that only a small fragment (trp134-Phe-Pro-Phe137) of the 
cys-loop is hydrophobic in nature and that it probably in-
teracts with the membrane portion of the receptor (Fig.1). 
At the same time, the homologous region of AchBP contains 
only hydrophilic residues (Fig.1). thus, the second mutant 
gene (α7ED/C116S/DTES) encodes α7eD with the replace-
ment of this hydrophobic site with Asp-thr-Glu-Ser from 
AchBP and the substitution of cys116Ser.
Mutant genes, with an additional sequence coding 
for a His 6-tag on the c-terminus, were cloned into the 
pET22b(+) vector. In both cases, the majority of the syn-
thesized protein was in the form of insoluble aggregates, 
and only a small percentage remained soluble (Fig.2, lanes 
2-4).  the most likely cause for the observed aggrega-
tion is the incorrect formation of disulfide bonds and/or 
the tendency of α7eD toward spontaneous pentameriza-
tion when in solution [9].  the addition of reduced (GSH) 
and oxidized (GSSG) glutathiones, in concentrations of 0.1 
mM and 0.5 mM, respectively, to the translation solution 
increased the yield of soluble proteins by up to 30% (Fig.2, 
lanes 5-7). the presence in the translation solution of a low-
molecular-weight nAchr agonist (carbamylcholine, cch) 
yielded similar results (Fig.2, lanes 8-10). the use of a soft, 
non-ionic detergent (Brij-35) at a concentration of 0.5% to 
prevent spontaneous pentamerization, together with GSH 
and GSSG, caused a significant decrease in the fraction 
of insoluble protein (Fig.2, lanes 11-13). It should be noted 
that both chimeras of α7eD displayed identical properties 
during the process of synthesis and during subsequent ma-
nipulations, so the experiment proceeded using only α7eD/
c116S/DteS.
Purification of the recombinant proteins using metal-af-
finity chromatography caused the proteins to precipitate.     
thus, the conditions for the refolding of α7eD/c116S/DteS 
from a precipitate of the translation mixture were deter-
mined. Several different approaches (for example, 8M urea, 
6M guanidine hydrochloride and 1% sodium laurylsarcosine, 
LS) for initial precipitate dissolution were tried. the highest 
efficiency was achieved using a mixture of 3M urea and 1% 
LS in the presence of Dtt. the refolding of α7eD/c116S/
DteS was carried out on metal-affinity resin by washing 
with GSSG/GSH in a descending concentration gradient of 
both LS and urea. However, the protein that was obtained 
turned out to be highly unstable in solution.  the alterna-
tive protocol involved the replacement of 1% LS with  0.1% 
β-dodecylmaltoside (DDM) or 0.1% dodecylphosphocholine 
(DPc). 
As a result, highly stable (more than 1 month at +40С) 
protein preparations, with a final yield of 1 mg per ml of the   
translation mixture, were obtained. the samples of α7eD/
c116S/DteS in DDM and DPc solution were analyzed us-
ing size-exclusion chromatography (Fig.3). In the case of 
DDM, recombinant α7eD was found in the form of large 
soluble aggregates (Fig.3). use of DPc yielded a much more 
homogenous (>90%) sample with an average particle diam-
eter of 7mm, which corresponds to a size of α7eD monomer 
(5 nm) associated with DPc micelle (4 nm). An analysis of 
the secondary structure of α7eD/c116S/DteS in DPc so-
lution using cD spectroscopy revealed a prevalence of the 
β-structure, which was in keeping with our expectations 
(Fig.3). the ability of α7eD/c116S/DteS in DPc solution 
to interact with nAchr antagonists was studied using nMr 
spectroscopy with an 15n-labeled long-chain neurotoxin 
Fig.1. Model of the spatial organization of nAChR [1]. Comparison 
of a model of α7ED [6] with the spatial structure of AChBP subunit [4]. 
Scheme of mutations.
Fig. 2. Electrophoresis analysis of the cell‑free synthesis of α7ED/
C116S/DTES. 1‑ markers of molecular weights; 2, 5, 8, 11 – total pro‑
tein fraction of translation mixture; 3, 6, 9, 12 – soluble protein fraction of 
translation mixture; 4, 7, 10, 13 ‑ insoluble protein fraction of translation 
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ntII/I obtained as in [10]. the ntII/I sample in DPc was 
titrated by α7eD/c116S/DteS, and an attenuation of the 
toxin signals in 1D 15n-HSQc spectra was observed (Fig. 4). 
An analysis of the attenuation curve revealed that one mol-
ecule of the domain cooperatively binds two molecules of the 
toxin (Hill coefficient approximately 1.8) and an apparent 
dissociation constant of approximately 2 mkM. 
In summary, we developed a new cell-free system 
for the production of the active extracellular domain of 
α7nAchr. the addition of DPc to the protein sample sta-
bilizes the domain in solution, preserves the secondary 
structure, and doesn’t prevent the binding of antagonists.   
the development of this system creates new possibilities 
for future structural-functional studies of nAchr/ligand 
interactions. 
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Fig.4. 1D 15N‑HSQC NMR spectrum of NTII/I toxin in the presence of DPC 
micelles and following an increase in α7ВД/C116S/DTES concentra‑
tions. The obtained isotherm binding and dilution curves (dashed line) 
are shown.
Fig.3. Analysis of α7ED/C116S/DTES in DDM and DPC solution using 
size‑exclusion chromatography on Superdex‑200 (GE Healthcare).  
CD spectrum of α7ED/C116S/DTES in DPC solution. 
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